The impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Gray, D M ^b   Zar, Heather J ^a   Cotton, M ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

CHILD; CHILDHOOD MORTALITY; CLINICAL TRIAL; COCHRANE LIBRARY; DATA ANALYSIS; DATA EXTRACTION; DRUG EFFECT; DRUG EFFICACY; EMBASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PUBLICATION; REVIEW; RISK REDUCTION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 44949169806     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006418     Document Type: Review

References (31)

1. Barnes 1991 Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. New England Journal of Medicine 1991;324:1644-50.
2. Berggren Palme 2002 Berggren Palme I, Gudetta B, Bruchfield J, Muhe L, Giesecke J. Impact of human immunodeficeincy virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatric Infectious Disease Journal 2002;21:1053-61.
3. Burman 2005 Burman WJ. Issues in the Managemnet of HIV-Related Tuberculosis. Clinics in Chest Medicine 2005;26:283-94.
4. Chintu 2005 Chintu C, Mwaba P. Tuberculosis in children with human immunodeficiency virus infection. The International Journal of Tuberculosis Lung Disease 2005;9(5):477-84.
5. Corbett 2003 Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al.The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Med 2003;163:1009-21.
6. Curtis 1999 Curtis AB, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J, et al.Extensive transmission of Mycobacterium tuberculosis from a child. New England Journal of Medicine 1999;341:1491-5.
7. Donald 2000 Donald PR. Childhood tuberculosis. Current Opinion in Pulmonary Medicine 2000;6:187-92.
8. Donald 2002 Donald PR. Childhood tuberculosis: out of control?. Current Opinion in Pulmonary Medicine 2002;8:178-82.
9. Foster 2003 Foster K, Alton H. Chronic lung infection in children. Paediatric Respiratory reviews 2003;4:225-9.
10. Goletti 1996 Goletti D, Weisman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al.Effect of mycobacterium tuberculosis on HIV replication: role of immune activation. Journal of Immunology 1996;157:1271-8.
11. Hesseling 2005 Hesseling AC, Westra AE, Werschkull H, Donald PR, Beyers N, Hussey GD, et al.Outcome of HIV infected children with culture confirmed tuberculosis. Archives of Disease in Childhood 2005;90:1171-4.
12. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
13. Higgins 2005 Higgins JPT, Green S, editors. Cochrane handbook for Systemic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.org/ resources/handbook/hbook.htm (accessed Feb 2006).
14. Jeena 1998 Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1-infected and uninfected African children. AIDS 1998;12:1185-93.
15. Jeena 2002 Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. The International Journal of Tuberculosis and Lung Disease 2002;6:672-8.
16. Kochi 1991 Kochi A. The global tuberculosis situation and the new strategy of the World Health Organisation. Tubercle 1991;72:1-6.
17. Marais 2005 Marais BJ, Obihara CC, Warren RM, Schaaf HS, Gie RP, Donald PR. The burden of childhood tuberculosis: a public health perspective. The International Journal of Tuberculosis and Lung Disease 2005;9(12):1305-13.
18. Mukadi 1997 Mukadi YD, Wiktor Z, Coulibaly IM, Coulibaly D, Mbengue A, Folquet AM, et al.Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997;11(9):1151-8.
19. Narita 1998 Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. American Journal of Respiratory and Critical Care Medicine 1998;158(1):157-61.
20. Nelson 2004 Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. The International Journal of Tuberculosis and Lung Disease 2004;8(5):636-47.
21. Perriens 1995 Perriens JH, St Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, et al.Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. New England Journal of Medicine 1995;332(12):779-84.
22. Puthanakit 2006 Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirianthana V. Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children. Pediatric Infectious Disease Journal 2006;25(1):53-8.
23. RevMan Analyses 2004 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [computer program]. 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2004.
24. Schaaf 1998 Schaaf HS, Geidenduys A, Gie RP, Cotton MF. Culture-positive tuberculosis in human immunodeficiency virus type-1-infected children. Pediatric Infectious Disease Journal 1998;7:599-604.
25. Schaaf 2005 Schaaf HS, Krook S, Hollemans DW, Warren RM, Donald PR, Hesseling AC. Recurrent Culture-Confirmed Tuberculosis in Human Immunodeficiency Virus-Infected Children. Pediatric Infect Disease Journal 2005;24(8):685-91.
26. Smieja 1999 Smieja MJ, Marchettu CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews 1999, Issue 1.Art. No.: CD001363. DOI: 10.1002/14651858.CD001363.
27. Thompson 1982 Thompson NJ. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of the World Health Organisation 1982;60:555-64.
28. UNAIDS/WHO 2005 UNAIDS/WHO. AIDS epidemic update: December 2005. www.unaids.org (accessed 23 February 2006).
29. van Rie 1999 van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factors. Archives of Disease in Childhood 1999;80:433-7.
30. Woldehanna 2004 Woldehanna S, Volmink J. Treatment of latent infection in HIV infected persons. Cochrane Database of Systematic Reviews 2004, Issue 1.
31. Zar 2001 Zar HJ, Manslo D, Tannebaum E, Klein M, Argent A, Eley B, et al.Aetiology and outcome of pneumonia in humman immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatrica 2001;90(2):119-25.